Gold Nanourchins Potentiate Intravesical Chemotherapy by Accelerating Drug Internalization within a Short Instillation Window

Abstract Intravesical chemotherapy is a standard adjuvant treatment for nonmuscle-invasive bladder cancer after transurethral resection, but its efficacy is limited by drug exposure resulting from urinary dilution and physiological voiding. Most current delivery strategies aim to prolong the intravesical residence through mucoadhesion, depot formation, or sustained release. Although these approaches increase local drug availability, they do not directly address insufficient intracellular drug accumulation during the short instillation window. Here, we report a poly-l-glutamic acid-modified gold nanourchin platform, PGU3@DOX, designed to enhance intravesical chemotherapy by accelerating drug internalization by bladder cancer cells. By optimizing the nanoparticle morphology, we identified long-spiked gold nanourchins as the most effective architecture for rapid cellular uptake. The PLG coating enabled doxorubicin loading and supported pH-facilitated DOX release, while the internalized nanourchins induced lysosomal swelling and lysosomal membrane permeabilization in bladder cancer cells. Under a 1 h pulse exposure that mimics the short intravesical dwell-time window, PGU3@DOX showed greater cytotoxicity against bladder cancer cells after extracellular drug removal while showing lower toxicity toward normal urothelial cells. Furthermore, PGU3@DOX achieved a broader distribution and stronger damage in tumor spheroids than free DOX. In an orthotopic bladder cancer model, a single short-duration intravesical administration of PGU3@DOX significantly suppressed tumor progression without detectable acute hematological, hepatic, renal, or cardiac toxicity under the tested conditions. These findings support rapid cellular internalization as a complementary strategy to improve intravesical chemotherapy and provide a morphology-guided nanocarrier platform for enhancing drug delivery within short therapeutic exposure windows.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-10-16
DOI
https://doi.org/10.1021/acsnano.6c10659
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gold Nanourchins Potentiate Intravesical Chemotherapy by Accelerating Drug Internalization within a Short Instillation Window

Jianjun Cheng, Menghua Xiong, Yaofeng Zhou, Yan Bao et al.
ACS Nano
Nanoparticle-Based Drug Delivery
article

Gold Nanourchins Potentiate Intravesical Chemotherapy by Accelerating Drug Internalization within a Short Instillation Window

Jianjun Cheng, Menghua Xiong, Yaofeng Zhou, Yan Bao, Haowei Rong, Menghua Gao, Peiyu Yu, Fei Feng, Xuefei Feng, Lei Zhang
article en

Abstract

Abstract Intravesical chemotherapy is a standard adjuvant treatment for nonmuscle-invasive bladder cancer after transurethral resection, but its efficacy is limited by drug exposure resulting from urinary dilution and physiological voiding. Most current delivery strategies aim to prolong the intravesical residence through mucoadhesion, depot formation, or sustained release. Although these approaches increase local drug availability, they do not directly address insufficient intracellular drug accumulation during the short instillation window. Here, we report a poly-l-glutamic acid-modified gold nanourchin platform, PGU3@DOX, designed to enhance intravesical chemotherapy by accelerating drug internalization by bladder cancer cells. By optimizing the nanoparticle morphology, we identified long-spiked gold nanourchins as the most effective architecture for rapid cellular uptake. The PLG coating enabled doxorubicin loading and supported pH-facilitated DOX release, while the internalized nanourchins induced lysosomal swelling and lysosomal membrane permeabilization in bladder cancer cells. Under a 1 h pulse exposure that mimics the short intravesical dwell-time window, PGU3@DOX showed greater cytotoxicity against bladder cancer cells after extracellular drug removal while showing lower toxicity toward normal urothelial cells. Furthermore, PGU3@DOX achieved a broader distribution and stronger damage in tumor spheroids than free DOX. In an orthotopic bladder cancer model, a single short-duration intravesical administration of PGU3@DOX significantly suppressed tumor progression without detectable acute hematological, hepatic, renal, or cardiac toxicity under the tested conditions. These findings support rapid cellular internalization as a complementary strategy to improve intravesical chemotherapy and provide a morphology-guided nanocarrier platform for enhancing drug delivery within short therapeutic exposure windows.

ACS Nano
Sun Yat-sen University (CN), Fudan University (CN), Westlake University (CN), Sun Yat-sen Memorial Hospital (CN), South China University of Technology (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Science and Technology Department of Zhejiang Province
Good health and well-being
Openalex Percentile: Top 29%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.